Nuclear Medicine Market: Global Market Size, Trends, Competitive, Historical & Forecast Analysis, 2019-2025

Report code: BMRC800 | Report Format: | 12-Feb-2019 | Number of pages: 188 | Post Publisher:BEMRC

The detailed market intelligence report on the Global Nuclear Medicine Market applies the most effective of each primary and secondary analysis to weighs upon the competitive landscape and also the outstanding market players expected to dominate Global Nuclear Medicine Market place for the forecast 2019– 2025.

Scope of Global Nuclear Medicine Market Reports –

Nuclear medicine is a branch of medical imaging which uses very small amount of radioactive material (Radiopharmaceuticals) to diagnose and treat variety of disease such as various forms of cancers, heart disease, gastrointestinal, endocrine, neurological disorders, and other abnormalities within the body.In Nuclear Medicineimaging the radioisotopes are identified by the special type of cameras connected to the computer which offersactualimage of the body part which was examined. Nuclear Medicines are radioactive materials that are injected into bloodstream or are swallowed in small amount through which they can help in early detection of diseases. By using radioactive material with pharmaceutical compounds used to detect a definite organ for imaging purposes, to check the development of disease in the body, concentrating on cellular function and physiology of the body. Nuclear medicine includes treatment of diseased tissues. Therapeutic nuclear medicines or used to treat an overactive thyroid gland – a condition known as hyperthyroidism or thyrotoxicosis.

Nuclear Medicine helps to find medical information that is not easily available or requires surgical procedure or costly and invasive diagnostic tests. It helps in detection of symptoms at a very early stage of a disease.

Global Nuclear Medicine Market has been segmented on the basis of Type, Procedural Volumes, Application, End User and Geography. On the basis ofType of Global Nuclear Medicine Market is classified into Diagnostic Nuclear Medicine,Therapeutic Nuclear Medicine, Research Nuclear Medicine and Other.On the basis of Procedural Volumes of Global Nuclear Medicine Market is classified intoDiagnostic Procedures,Therapeutic Procedures and Other.On the basis of ApplicationGlobal Nuclear Medicine Market is classified intoOncology,Cardiology, Neurology, Thyroid, Lymphoma, Endocrinology and others.On the basis of End User Global Nuclear Medicine Market is classified intodiagnostic centers, hospitals, research centers and others.  The regions covered in Global Nuclear Medicine Market report are North America, Europe, Asia-Pacific and Rest of the World. On the basis of country level, Global Melanoma Drug Market sub divided in to U.S., Mexico, Canada, U.K., France, Germany, Italy, China, Japan, India, South East Asia, GCC, Africa, etc.

Key Players for Global Nuclear Medicine Market Reports –

Global Nuclear Medicine Marketreports cover prominent players like Cardinal Health Inc., Mallinckrodt plc, GE Healthcare, Lantheus Medical Imaging, Inc., Bayer AG, Bracco Imaging S.p.A, Eczacibasi-Monrol Nuclear Products, Advanced Accelerator Applications S.A., IBA Molecular Imaging, Mallinckrodt plc, Cardinal Health Inc., Curium, Lantheus Medical Imgaging, Triad Isotopes, Siemens Healthineer, Bracco, Cambridge Isotope Laboratories Inc., Nordion Inc., Fujifilm Holdings Corporation, Philips Healthcare, Digirad, Ashby Gorman Baker Ltd, Lantheus Medical Imaging Inc., Jubilant Life Sciences and NTP Radioisotopes SOC Ltd.

Nuclear Medicine Market Dynamics –

Growth of the overallGlobal Nuclear Medicine Market can be attributed to factors such as the increasing incidences of cancer and cardiovascular disorders, development of alpha radiotherapy and funds through public-private partnerships.Growing occurrence of cardiac patients and acceptance of clear imaging method, with the help of diagnostic equipment such as PET (Positron Emission Tomography) and SPECT (Single Photon Emission Computed Tomography). Moreover, themanufacture of MO-99 in the U.S. approval of Nuclear Medicine by the FDA, new irradiation capacity in Germany, system of PET scanners in India, funds by the government in the Rest of Asia-Pacific and initiatives of IAEA (International Atomic Energy Agency) is enhancing theGlobal Nuclear Medicine Market.The factors that restrain the growth of the Global Nuclear Medicine Market includeHigh cost of medicinessuch asmore than $100 million, supply shortages, logistical difficulties and limited number of trained medical personnel.Also, stringent government regulation for drug approval are keyreasonshindering growth of the Global Nuclear Medicine Market.Furthermore, reimbursement obstacles for the manufacturer and high money investment are also restraining the Global Nuclear Medicine Market growth. Moreover, advancements in scanning technology are increasing the effectiveness of diagnosis using radioisotopes and as a consequence application areas of current radioisotopes are quickly growing. Extensiveuses of the existing products united with introduction of newer radioisotopes for the diagnosis of respiratory, bones and thyroid related diseases are increasing the growth of nuclear medicines in the Global Nuclear Medicine Market.

High accurateness, capacity to integrate with other diagnostic techniques such as x-ray and growing awareness of this technique in the developing market are the main factors likely to fuel the market growth of the diagnostic nuclear medicines during the forecast period.

Global Nuclear Medicine Market Regional Analysis –

From a geographical standpoint, North America is the dominant market in 2017and occupied around 40% of the overall market revenue. In North America the United States is the major consumer market for Nuclear Medicine and Canada is the largest producer of Tc-99m.It is due to the widespread awareness of the use of radioisotopes and radiation in medicine for various medical conditions. In the developed countries, the frequency of diagnostic and therapeutic nuclear medicine is rising exponentially. Asia Pacific is projected to outshine all other regions in the upcoming years, mainly driven by Japan, China, Australia, and India nations where the fastest growth in the region are rising healthcare spending and increasing awareness of Nuclear Medicine among healthcare providers. The huge population, increasing occurrences of neurological and cardiovascular diseases as well as various types of cancer is also contributory to the growth of Global Nuclear Medicine Market in Asia Pacific.

Key Benefits for Nuclear Medicine Market Reports 

  • Global market report covers in-depth historical and forecast analysis.
  • Global market research report provides detail information about Market Introduction, Market Summary, Global market Revenue (Revenue USD), Market Drivers, Market Restraints, Market Opportunities, Competitive Analysis, Regional and Country Level.
  • Global market report helps to identify opportunities in market place.
  • Global market report covers extensive analysis of emerging trends and competitive landscape.

Nuclear Medicine Market Segmentation:

By Type

  • Diagnostic
  • Therapeutic

By Modality

  • SPECT
  • PET
  • Alpha-emitters
  • Beta-emitters
  • Brachytherapy

By Application

  • Oncology
  • Cardiology
  • Neurology
  • Thyroid
  • Others

By Procedures

  • Oncology
  • Cardiovascular
  • Central Nervous System
  • Endocrine
  • Skeletal
  • Gastrointestinal
  • Genito-urinary
  • Pulmonary
  • PET & PET-CT
  • Therapeutic
  • Others

By End-user

  • Hospitals and diagnostic centers
  • Research institutes

By Region

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • UK
    • France
    • Germany
    • Russia
    • Rest of Europe
  • Asia-Pacific
    • China
    • South Korea
    • India
    • Japan
    • Rest of Asia-Pacific
  • LAMEA
    • Latin America
    • Middle East
    • Africa

Nuclear Medicine Market Key Players:

  • Eckert & Ziegler Group
  • Mallinckrodt
  • GE Healthcare
  • Jubilant Life Sciences Ltd.
  • Bracco Imaging S.P.A
  • Nordion, Inc.
  • The Institute For Radioelements (IRE)
  • Australian Nuclear Science & Technology Organization (ANSTO)
  • NTP Radioisotopes SOC Ltd.
  • Eczacibasi – Monrol

This comprehensive report will provide:

  • Enhance your strategic decision making
  • Assist with your research, presentations and business plans
  • Show which emerging market opportunities to focus on
  • Increase your industry knowledge
  • Keep you up-to-date with crucial market developments
  • Allow you to develop informed growth strategies
  • Build your technical insight
  • Illustrate trends to exploit
  • Strengthen your analysis of competitors
  • Provide risk analysis, helping you avoid the pitfalls other companies could make
  • Ultimately, help you to maximize profitability for your company.

Our Market Research Solution Provides You Answer to Below Mentioned Question:

  • Which are the driving factors responsible for the growth of market?
  • Which are the roadblock factors of this market?
  • What are the new opportunities, by which market will grow in coming years?
  • What are the trends of this market?
  • Which are main factors responsible for new product launch?
  • How big is the global & regional market in terms of revenue, sales and production?
  • How far will the market grow in forecast period in terms of revenue, sales and production?
  • Which region is dominating the global market and what are the market shares of each region in the overall market in 2017?
  • How will each segment grow over the forecast period and how much revenue will these segment account for in 2025?
  • Which region has more opportunities?

Eckert & Ziegler Group
Mallinckrodt
GE Healthcare
Jubilant Life Sciences Ltd.
Bracco Imaging S.P.A
Nordion, Inc.
The Institute For Radioelements (IRE)
Australian Nuclear Science & Technology Organization (ANSTO)
NTP Radioisotopes SOC Ltd.
Eczacibasi – Monrol